Influence of probiotics on rat liver biotransformation enzymes

Neuroendocrinology Letters

Volumn 30, Issue SUPPL.1, 2009, Pages 41-45

  Matuskova, Zuzana ^a   Tunkova, Alena ^a   Anzenbacherova, Eva ^a   Zidek, Zdenek ^b   Tlaskalova Hogenova, Helena ^c   Anzenbacher, Pavel ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Bacterial lipopolysaccharide; Cytochrome P450; Escherichia coli; Probiotic; Rat liver

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C6; CYTOCHROME P450 2C9; CYTOCHROME P450 3A1; PHENOL; PROBIOTIC AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ESCHERICHIA COLI; FEMALE; LIVER MICROSOME; LUMINESCENCE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 77349086150     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bruyere A, Decleves X, Bouzom F, Proust L, Martinet M, Walther B, et al. (2009). Development of an optimized procedure for the preparation of rat intestinal microsomes: comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains. Xenobiotica. 39: 22-32.
2. Chang TKH, Waxman DJ (1998). Enzymatic analysis of cDNA-expresed human CYP1A1, CYP1A2 and CYP1B1 with ethoxyresorufin as a substrate. In: Phillips IR, Shephard EA, editors. Cytochrome P450 Protocols. Totowa, NJ: Humana. p. 103-122.
3. Crespi CL, Chang TKH, Waxman DJ (1998). Determination of CYP2C9-catalyzed diclofenac 4′-hydroxylation by high-performance liquid chromatography. In: Phillips IR, Shephard EA, editors. Cytochrome P450 Protocols. Totowa, NJ: Humana. p. 129-133.
4. Donato MT, Jimenez N, Castell JV, Gomez-Lechon MJ (2004). Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos. 32: 699-706.
5. Evans WE, Relling MV (1999). Pharmacogenomics: Translating function genomics into rational therapeutics. Science. 286: 487-491.
6. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report.
7. www.fao.org/es/ESN/Probio/probio.htm, accessed June 12, 2009.
8. Guarner F, Malagelada JR (2003). Gut flora in health and disease. The Lancet. 361: 512-519.
9. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986). Characterization of rat human-liver microsomal cytochrome-P-450 forms involved in nifedipine oxidation, a prototype for genetic-polymorphism in oxidative drug-metabolism. J Biol Chem. 261: 5051-5060.
10. Krizkova J, Burdova K, Hudecek J, Stiborova M, Hodek P (2008). Induction of cytochromes P450 in small intestine by chemopreventive compounds. Neuroendocrinol Lett. 29: 717-721.
11. Masubuchi Y, Ose A, Horie T (2001). Mechanism-based inactivation of CYP2C11 by diclofenac. Drug Metab Disposition. 29: 1190-1195.
12. Omura T, Sato R (1964).The carbon-monoxide binding protein of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem. 239: 2370-2378.
13. Towbin H, Staehelin T, Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci USA. 76: 4350-4353.
14. Preidis GA, Versalovic J (2009).Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology. 136: 2015-2031.
15. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT (1999). Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. The Lancet. 354: 635-639.
16. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C, et al (2004). Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol. 11: 372-378.
17. Sistkova J, Hudecek J, Hodek P, Frei E, Schmeiser H, Stiborova M (2008). Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid. Neuroendocrinol Lett. 29: 733-737.
18. Soucek P (1999). Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation. J Chromatogr B. 734: 23-29.
19. Wang H, Cheng JD, Montgomery D, Cheng KC (2009). Evaluation of the binding orientations of testosterone in the active site of homology models for CYP2C11 and CYP2C13. Biochem Pharmacol. 78: 406-413.
20. Yang KH, Lee MG (2008). Effects of endotoxin derived from Escherichia coli lipopolysaccharide on the pharmacokinetics of drugs. Arch Pharm Res. 31: 1073-1086.